Immediate Impact
1 by Nobel laureates 24 from Science/Nature 70 standout
Citing Papers
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
2022 Standout
Works of Daniela S. Bundschuh being referenced
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
2009
In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniela S. Bundschuh | 557 | 315 | 323 | 552 | 15 | 1.2k | |
| S. A. Marsico | 644 | 241 | 380 | 743 | 45 | 1.5k | |
| Katja Hattar | 632 | 330 | 180 | 579 | 32 | 1.6k | |
| Rolf Beume | 597 | 218 | 666 | 510 | 27 | 1.2k | |
| Suzanne Traves | 600 | 468 | 313 | 657 | 31 | 1.5k | |
| Kazuhiro Ito | 470 | 219 | 188 | 498 | 14 | 1.1k | |
| J. Madden | 700 | 409 | 276 | 229 | 30 | 1.6k | |
| Monika Ermert | 209 | 276 | 216 | 585 | 21 | 1.2k | |
| Nicolas Mercado | 452 | 233 | 529 | 543 | 29 | 1.3k | |
| Ognjen Čulić | 307 | 208 | 599 | 307 | 33 | 1.5k | |
| Michael J. Peck | 430 | 263 | 372 | 329 | 29 | 1.5k |
All Works
Loading papers...